Minot Wealth Management’s PAVmed PAVM Stock Holding History

Minot Wealth Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-67	Closed	-$256K	–	210
2021 Q3	$256K	Hold	67	–	–	0.06%	172
2021 Q2	$168K	Buy	+67	New	+$158K	0.04%	194

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Minot Wealth Management's PAVM Position: Q4 2021 in Review

Minot Wealth Management sold out of PAVmed (PAVM) in Q4 2021, closing a stake of 67 shares — an estimated $256K sold.

Minot Wealth Management first reported a position in PAVM in Q2 2021 and held it in 2 quarters. The position peaked at $256K in Q3 2021. 105 funds tracked by Wall St. Rank hold PAVM as of Q4 2021.

Minot Wealth Management reported no remaining PAVmed position as of Q4 2021 after selling out during the quarter.
Minot Wealth Management sold 67 PAVmed shares in Q4 2021, an estimated $256K.
Minot Wealth Management first reported a position in PAVmed in Q2 2021 and held it in 2 quarters.
Minot Wealth Management's PAVmed position peaked at $256K in Q3 2021.
105 funds tracked by Wall St. Rank held PAVmed as of Q4 2021.

Based on Minot Wealth Management's 13F filing for Q4 2021, filed 20 Jan 2022.